UBS Group
NXTM

UBS Group’s NxStage Medical Inc. NXTM Stock Holding History

UBS Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,000
Closed -$865K – 9045
2015
Q1 		$865K Buy
+50,000
New +$883K ﹤0.01% 3696

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

UBS Group's NXTM Position: Q1 2019 in Review

UBS Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 893,856 shares — an estimated $25.6M sold.

UBS Group first reported a position in NXTM in Q4 2014 and held it in 17 quarters. The position peaked at $27.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • UBS Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • UBS Group sold 893,856 NxStage Medical Inc. shares in Q1 2019, an estimated $25.6M.
  • UBS Group first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 17 quarters.
  • UBS Group's NxStage Medical Inc. position peaked at $27.8M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.